Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf7
|
ENSMUSG00000025959.7 | Kruppel-like factor 7 (ubiquitous) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_64118062_64118257 | Klf7 | 3323 | 0.249547 | 0.66 | 5.0e-08 | Click! |
chr1_64118397_64118548 | Klf7 | 3010 | 0.261359 | 0.59 | 2.3e-06 | Click! |
chr1_64105208_64105595 | Klf7 | 16081 | 0.175801 | 0.37 | 6.0e-03 | Click! |
chr1_64120071_64120237 | Klf7 | 1328 | 0.454812 | -0.35 | 8.0e-03 | Click! |
chr1_64119771_64120041 | Klf7 | 1576 | 0.398522 | -0.35 | 8.9e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_137596675_137597031 | 25.44 |
Mospd3 |
motile sperm domain containing 3 |
3838 |
0.08 |
chr16_49839698_49840015 | 21.28 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
15510 |
0.24 |
chr7_120842635_120843705 | 16.65 |
Eef2k |
eukaryotic elongation factor-2 kinase |
339 |
0.84 |
chr11_82847751_82847915 | 16.43 |
Rffl |
ring finger and FYVE like domain containing protein |
1741 |
0.23 |
chr5_137103357_137103516 | 14.93 |
Trim56 |
tripartite motif-containing 56 |
12771 |
0.11 |
chr15_89196330_89196838 | 14.33 |
Dennd6b |
DENN/MADD domain containing 6B |
88 |
0.94 |
chr10_117120377_117120534 | 13.89 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
10391 |
0.15 |
chr9_71162797_71162981 | 13.42 |
Aqp9 |
aquaporin 9 |
256 |
0.84 |
chr9_90237740_90238196 | 13.21 |
Gm16200 |
predicted gene 16200 |
16343 |
0.15 |
chr5_104062794_104062959 | 12.75 |
Gm43333 |
predicted gene 43333 |
9449 |
0.1 |
chr16_87713410_87713580 | 12.36 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
14491 |
0.2 |
chr9_113970114_113970391 | 11.73 |
Gm47950 |
predicted gene, 47950 |
746 |
0.49 |
chr19_4059281_4059805 | 11.36 |
Gstp3 |
glutathione S-transferase pi 3 |
26 |
0.92 |
chr11_97884065_97884612 | 11.24 |
Fbxo47 |
F-box protein 47 |
184 |
0.58 |
chrX_7057531_7057935 | 10.98 |
Akap4 |
A kinase (PRKA) anchor protein 4 |
9786 |
0.2 |
chr19_5726991_5727271 | 10.82 |
Gm16538 |
predicted gene 16538 |
75 |
0.87 |
chr2_93462782_93463077 | 10.71 |
Cd82 |
CD82 antigen |
17 |
0.98 |
chr1_195092547_195092740 | 10.57 |
Cd46 |
CD46 antigen, complement regulatory protein |
394 |
0.77 |
chr17_39848426_39848686 | 10.48 |
CT010467.2 |
|
271 |
0.89 |
chr4_100994668_100995090 | 10.37 |
Cachd1 |
cache domain containing 1 |
169 |
0.95 |
chrX_36807727_36808286 | 10.37 |
Gm14549 |
predicted gene 14549 |
6765 |
0.13 |
chr2_73002029_73002223 | 10.35 |
Sp3os |
trans-acting transcription factor 3, opposite strand |
14885 |
0.14 |
chr2_93456201_93456461 | 10.24 |
Gm10804 |
predicted gene 10804 |
3510 |
0.2 |
chr19_58441868_58442054 | 10.24 |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
12505 |
0.22 |
chr16_4541512_4542439 | 10.19 |
Srl |
sarcalumenin |
159 |
0.93 |
chr4_136177837_136178388 | 10.11 |
E2f2 |
E2F transcription factor 2 |
2671 |
0.2 |
chr17_29438373_29438671 | 9.77 |
Gm36486 |
predicted gene, 36486 |
1074 |
0.38 |
chr4_132077386_132077728 | 9.74 |
Epb41 |
erythrocyte membrane protein band 4.1 |
2236 |
0.17 |
chr15_79057887_79058175 | 9.72 |
Ankrd54 |
ankyrin repeat domain 54 |
2618 |
0.11 |
chr18_42510920_42511513 | 9.70 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr11_107092787_107092963 | 9.65 |
Bptf |
bromodomain PHD finger transcription factor |
25670 |
0.14 |
chr5_140606846_140607467 | 9.59 |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
164 |
0.83 |
chr12_70227533_70227906 | 9.58 |
Pygl |
liver glycogen phosphorylase |
36 |
0.6 |
chr7_132723876_132724242 | 9.51 |
Fam53b |
family with sequence similarity 53, member B |
52857 |
0.11 |
chr13_114680122_114680324 | 9.36 |
4930544M13Rik |
RIKEN cDNA 4930544M13 gene |
72986 |
0.09 |
chr4_62516095_62516402 | 9.34 |
Alad |
aminolevulinate, delta-, dehydratase |
3633 |
0.14 |
chr11_19924323_19926342 | 9.33 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr16_32449795_32449957 | 9.30 |
2210020O09Rik |
RIKEN cDNA 2210020O09 gene |
6273 |
0.12 |
chr1_91251998_91252212 | 9.24 |
Ube2f |
ubiquitin-conjugating enzyme E2F (putative) |
1449 |
0.34 |
chr1_166811378_166811537 | 9.23 |
Gm37904 |
predicted gene, 37904 |
12618 |
0.22 |
chr7_90062841_90063193 | 9.19 |
Gm44861 |
predicted gene 44861 |
20320 |
0.11 |
chr7_99141062_99141898 | 9.16 |
Gm45185 |
predicted gene 45185 |
113 |
0.76 |
chr1_166812014_166812333 | 9.12 |
Gm37904 |
predicted gene, 37904 |
13334 |
0.22 |
chr7_100466963_100467472 | 9.05 |
Gm10603 |
predicted gene 10603 |
27 |
0.95 |
chr5_140597401_140597576 | 8.99 |
Gm43703 |
predicted gene 43703 |
9063 |
0.13 |
chrX_51204673_51205680 | 8.97 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr2_70826966_70827122 | 8.92 |
Tlk1 |
tousled-like kinase 1 |
1316 |
0.47 |
chr1_58956241_58956597 | 8.90 |
Trak2 |
trafficking protein, kinesin binding 2 |
10082 |
0.15 |
chr8_85380323_85380758 | 8.90 |
Mylk3 |
myosin light chain kinase 3 |
438 |
0.77 |
chr7_126975552_126976438 | 8.86 |
Cdiptos |
CDIP transferase, opposite strand |
57 |
0.51 |
chr7_135601722_135601885 | 8.86 |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
4025 |
0.22 |
chr5_146271832_146271998 | 8.84 |
Cdk8 |
cyclin-dependent kinase 8 |
14122 |
0.14 |
chr11_103106503_103106752 | 8.80 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
423 |
0.74 |
chr1_90289239_90289505 | 8.80 |
Gm28723 |
predicted gene 28723 |
8914 |
0.18 |
chr8_70698268_70700333 | 8.67 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr17_84957544_84957954 | 8.67 |
1110020A21Rik |
RIKEN cDNA 1110020A21 gene |
39 |
0.77 |
chr11_22793660_22793820 | 8.63 |
Gm12058 |
predicted gene 12058 |
6493 |
0.15 |
chr3_152114756_152115116 | 8.59 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
6414 |
0.15 |
chr18_68230237_68230503 | 8.52 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
2303 |
0.29 |
chr10_70127025_70127241 | 8.48 |
Ccdc6 |
coiled-coil domain containing 6 |
30012 |
0.2 |
chr8_10974164_10974480 | 8.42 |
Gm44956 |
predicted gene 44956 |
3508 |
0.15 |
chr2_167431166_167431353 | 8.40 |
Slc9a8 |
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
7140 |
0.18 |
chr2_125864448_125864599 | 8.34 |
Galk2 |
galactokinase 2 |
1584 |
0.41 |
chr6_55339223_55339486 | 8.33 |
Aqp1 |
aquaporin 1 |
2922 |
0.21 |
chr5_137530580_137532081 | 8.26 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr16_17638547_17638739 | 8.26 |
Smpd4 |
sphingomyelin phosphodiesterase 4 |
56 |
0.95 |
chr6_90712861_90713488 | 8.17 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
3355 |
0.21 |
chr4_152107387_152107889 | 8.16 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
2 |
0.96 |
chr14_55540009_55540830 | 8.14 |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
6 |
0.92 |
chr17_28800512_28801462 | 8.14 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
103 |
0.88 |
chr11_49713043_49713524 | 8.01 |
Cnot6 |
CCR4-NOT transcription complex, subunit 6 |
560 |
0.67 |
chr6_142530512_142530805 | 7.95 |
Ldhb |
lactate dehydrogenase B |
22701 |
0.16 |
chr18_32556691_32557012 | 7.91 |
Gypc |
glycophorin C |
3129 |
0.27 |
chr12_69759638_69759805 | 7.79 |
Mir681 |
microRNA 681 |
4223 |
0.15 |
chr18_82568694_82569112 | 7.74 |
Mbp |
myelin basic protein |
5641 |
0.19 |
chr4_155120855_155121072 | 7.73 |
Morn1 |
MORN repeat containing 1 |
10273 |
0.15 |
chr7_25686729_25687529 | 7.72 |
Tgfb1 |
transforming growth factor, beta 1 |
127 |
0.91 |
chr10_127289823_127290184 | 7.66 |
Gm4189 |
predicted gene 4189 |
721 |
0.25 |
chr11_59838964_59839223 | 7.64 |
Nt5m |
5',3'-nucleotidase, mitochondrial |
354 |
0.63 |
chr18_82522843_82523026 | 7.64 |
Rpl21-ps8 |
ribosomal protein L21, pseudogene 8 |
1087 |
0.51 |
chr2_120153745_120155075 | 7.63 |
Ehd4 |
EH-domain containing 4 |
52 |
0.97 |
chr4_135852077_135852234 | 7.61 |
Gm13000 |
predicted gene 13000 |
1523 |
0.25 |
chr13_58523787_58523959 | 7.61 |
Gm3131 |
predicted gene 3131 |
22155 |
0.16 |
chr15_82340761_82340945 | 7.60 |
Pheta2 |
PH domain containing endocytic trafficking adaptor 2 |
5 |
0.61 |
chr14_20180767_20181061 | 7.57 |
Kcnk5 |
potassium channel, subfamily K, member 5 |
895 |
0.49 |
chr5_99387512_99387943 | 7.52 |
Gm35394 |
predicted gene, 35394 |
113632 |
0.05 |
chr17_78289811_78289977 | 7.43 |
Crim1 |
cysteine rich transmembrane BMP regulator 1 (chordin like) |
9711 |
0.19 |
chr12_111813927_111814649 | 7.42 |
Zfyve21 |
zinc finger, FYVE domain containing 21 |
47 |
0.85 |
chr8_117335496_117335706 | 7.35 |
Cmip |
c-Maf inducing protein |
13569 |
0.25 |
chr10_117106272_117106596 | 7.34 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
24412 |
0.12 |
chr3_108096711_108096990 | 7.31 |
Gnat2 |
guanine nucleotide binding protein, alpha transducing 2 |
393 |
0.71 |
chr15_98606348_98606519 | 7.26 |
Adcy6 |
adenylate cyclase 6 |
1200 |
0.28 |
chr11_77800834_77801396 | 7.25 |
Myo18a |
myosin XVIIIA |
183 |
0.93 |
chrX_123721926_123722462 | 7.21 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chr11_98580923_98581253 | 7.20 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
6280 |
0.11 |
chr2_25195231_25195424 | 7.19 |
Tor4a |
torsin family 4, member A |
1432 |
0.16 |
chr9_106398083_106398486 | 7.18 |
Dusp7 |
dual specificity phosphatase 7 |
23665 |
0.09 |
chr15_99029765_99030391 | 7.17 |
Tuba1c |
tubulin, alpha 1C |
187 |
0.88 |
chr5_75579677_75580240 | 7.17 |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
5003 |
0.24 |
chr11_20916878_20917162 | 7.17 |
Gm23681 |
predicted gene, 23681 |
20681 |
0.18 |
chr4_12087867_12088383 | 7.16 |
Tmem67 |
transmembrane protein 67 |
118 |
0.93 |
chr5_115631459_115631653 | 7.11 |
1110006O24Rik |
RIKEN cDNA 1110006O24 gene |
260 |
0.56 |
chr15_44457390_44457901 | 7.07 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
92 |
0.97 |
chr16_20702522_20702892 | 7.01 |
Clcn2 |
chloride channel, voltage-sensitive 2 |
6027 |
0.08 |
chr11_110463266_110463565 | 7.01 |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
13962 |
0.27 |
chr17_26933146_26933765 | 6.99 |
Phf1 |
PHD finger protein 1 |
5 |
0.91 |
chr6_71801135_71801300 | 6.97 |
Gm44770 |
predicted gene 44770 |
1671 |
0.24 |
chrX_123943434_123943951 | 6.97 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr17_35469976_35470149 | 6.97 |
H2-Q10 |
histocompatibility 2, Q region locus 10 |
27 |
0.94 |
chr6_47788375_47788744 | 6.97 |
Rpl31-ps7 |
ribosomal protein L31, pseudogene 7 |
2185 |
0.21 |
chr10_128094363_128094673 | 6.96 |
Baz2a |
bromodomain adjacent to zinc finger domain, 2A |
1735 |
0.16 |
chr13_97137805_97138331 | 6.95 |
Gfm2 |
G elongation factor, mitochondrial 2 |
28 |
0.62 |
chr10_127380225_127380594 | 6.90 |
R3hdm2 |
R3H domain containing 2 |
82 |
0.94 |
chr2_13384961_13385636 | 6.90 |
Cubn |
cubilin (intrinsic factor-cobalamin receptor) |
70329 |
0.1 |
chr13_81643178_81643470 | 6.88 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
10170 |
0.18 |
chrX_123271195_123271712 | 6.86 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chr16_56716546_56717428 | 6.86 |
Tfg |
Trk-fused gene |
195 |
0.95 |
chr18_38296840_38297226 | 6.84 |
Rnf14 |
ring finger protein 14 |
2 |
0.93 |
chr11_57986582_57986738 | 6.82 |
Gm12249 |
predicted gene 12249 |
13526 |
0.15 |
chr1_167271742_167272080 | 6.79 |
Uck2 |
uridine-cytidine kinase 2 |
12690 |
0.11 |
chr13_64248561_64248803 | 6.79 |
1810034E14Rik |
RIKEN cDNA 1810034E14 gene |
18 |
0.5 |
chr6_125473324_125473663 | 6.79 |
Cd9 |
CD9 antigen |
4809 |
0.17 |
chr14_25745467_25745807 | 6.78 |
Zcchc24 |
zinc finger, CCHC domain containing 24 |
23402 |
0.13 |
chr1_179805903_179806068 | 6.78 |
Ahctf1 |
AT hook containing transcription factor 1 |
2305 |
0.27 |
chr1_195091756_195092192 | 6.76 |
Cd46 |
CD46 antigen, complement regulatory protein |
251 |
0.87 |
chrX_123500550_123501093 | 6.71 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr1_133133454_133133776 | 6.71 |
Gm26616 |
predicted gene, 26616 |
1833 |
0.26 |
chr12_112829543_112830189 | 6.66 |
Cdca4 |
cell division cycle associated 4 |
443 |
0.7 |
chr11_46439187_46439358 | 6.63 |
Med7 |
mediator complex subunit 7 |
380 |
0.8 |
chr10_127730571_127730933 | 6.62 |
Tac2 |
tachykinin 2 |
2905 |
0.11 |
chr19_5665499_5665819 | 6.61 |
Pcnx3 |
pecanex homolog 3 |
539 |
0.5 |
chr15_76666919_76667259 | 6.61 |
Foxh1 |
forkhead box H1 |
2713 |
0.1 |
chr17_34898151_34899707 | 6.60 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr11_53483383_53483573 | 6.57 |
Sowaha |
sosondowah ankyrin repeat domain family member A |
3204 |
0.1 |
chr4_135706113_135706270 | 6.57 |
Gm12989 |
predicted gene 12989 |
10407 |
0.13 |
chr12_110978382_110979023 | 6.53 |
Ankrd9 |
ankyrin repeat domain 9 |
84 |
0.95 |
chr14_20885136_20885450 | 6.53 |
Gm6128 |
predicted pseudogene 6128 |
28872 |
0.14 |
chr1_87532522_87532676 | 6.47 |
Gm6153 |
predicted gene 6153 |
12093 |
0.13 |
chr10_128187495_128187653 | 6.46 |
Gm4556 |
predicted gene 4556 |
2955 |
0.11 |
chr2_126675472_126675685 | 6.43 |
Gabpb1 |
GA repeat binding protein, beta 1 |
10 |
0.84 |
chr15_83565988_83566226 | 6.40 |
Tspo |
translocator protein |
2232 |
0.18 |
chr5_139196928_139197208 | 6.39 |
Sun1 |
Sad1 and UNC84 domain containing 1 |
3569 |
0.17 |
chr12_110974784_110974987 | 6.32 |
Ankrd9 |
ankyrin repeat domain 9 |
3370 |
0.15 |
chr13_20150160_20150481 | 6.31 |
Elmo1 |
engulfment and cell motility 1 |
34887 |
0.21 |
chr16_14162766_14163831 | 6.30 |
Nde1 |
nudE neurodevelopment protein 1 |
0 |
0.52 |
chr13_109685222_109685796 | 6.27 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
647 |
0.84 |
chr12_71978717_71979108 | 6.25 |
Gm7986 |
predicted gene 7986 |
70347 |
0.09 |
chr1_87636784_87636958 | 6.25 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
15197 |
0.16 |
chr13_9018934_9019095 | 6.24 |
Gtpbp4 |
GTP binding protein 4 |
22931 |
0.1 |
chr11_51841309_51841493 | 6.23 |
Jade2 |
jade family PHD finger 2 |
15724 |
0.17 |
chr12_84969258_84969593 | 6.18 |
Arel1 |
apoptosis resistant E3 ubiquitin protein ligase 1 |
1399 |
0.27 |
chr3_51224329_51224728 | 6.18 |
Noct |
nocturnin |
58 |
0.97 |
chr11_69016257_69016458 | 6.16 |
Ctc1 |
CTS telomere maintenance complex component 1 |
223 |
0.83 |
chr14_86721825_86722125 | 6.14 |
Gm49159 |
predicted gene, 49159 |
14790 |
0.23 |
chr17_50070230_50070402 | 6.14 |
Rftn1 |
raftlin lipid raft linker 1 |
24016 |
0.18 |
chr17_71259849_71260024 | 6.13 |
Emilin2 |
elastin microfibril interfacer 2 |
3590 |
0.2 |
chr6_31658824_31659102 | 6.13 |
Gm43154 |
predicted gene 43154 |
4929 |
0.2 |
chr4_133872994_133873306 | 6.11 |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
111 |
0.88 |
chr11_74556072_74556357 | 6.10 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
33463 |
0.15 |
chr13_58215850_58216388 | 6.09 |
Ubqln1 |
ubiquilin 1 |
466 |
0.68 |
chr13_23739207_23740153 | 6.08 |
H1f2 |
H1.2 linker histone, cluster member |
872 |
0.22 |
chr4_130297144_130297500 | 6.07 |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
11273 |
0.14 |
chr15_82004414_82004679 | 6.01 |
Xrcc6 |
X-ray repair complementing defective repair in Chinese hamster cells 6 |
10973 |
0.08 |
chrX_94540282_94541447 | 5.99 |
Maged1 |
melanoma antigen, family D, 1 |
1126 |
0.39 |
chr10_94688801_94689397 | 5.98 |
Cep83 |
centrosomal protein 83 |
381 |
0.56 |
chr8_126497512_126498658 | 5.98 |
Gm6091 |
predicted pseudogene 6091 |
21673 |
0.18 |
chr14_30577747_30577915 | 5.97 |
Mir3076 |
microRNA 3076 |
5682 |
0.15 |
chr14_75837044_75838069 | 5.97 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr7_27592613_27592899 | 5.97 |
Akt2 |
thymoma viral proto-oncogene 2 |
298 |
0.83 |
chr15_58932142_58932296 | 5.96 |
Tatdn1 |
TatD DNase domain containing 1 |
1149 |
0.33 |
chr12_84284873_84285073 | 5.95 |
Ptgr2 |
prostaglandin reductase 2 |
259 |
0.87 |
chr3_95893729_95894624 | 5.94 |
Aph1a |
aph1 homolog A, gamma secretase subunit |
121 |
0.9 |
chr4_57114662_57114816 | 5.94 |
Epb41l4b |
erythrocyte membrane protein band 4.1 like 4b |
5321 |
0.25 |
chr3_153800773_153801021 | 5.93 |
5730460C07Rik |
RIKEN cDNA 5730460C07 gene |
8810 |
0.12 |
chr11_69510905_69511069 | 5.91 |
Gm27493 |
predicted gene, 27493 |
5552 |
0.1 |
chr12_54985296_54986516 | 5.91 |
Baz1a |
bromodomain adjacent to zinc finger domain 1A |
30 |
0.91 |
chr2_69206712_69206868 | 5.90 |
Spc25 |
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
596 |
0.68 |
chr3_146405802_146406427 | 5.90 |
Ssx2ip |
synovial sarcoma, X 2 interacting protein |
1136 |
0.38 |
chr11_30158507_30158697 | 5.89 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
39655 |
0.16 |
chr3_102165876_102166166 | 5.89 |
Vangl1 |
VANGL planar cell polarity 1 |
81 |
0.96 |
chr7_120865040_120865504 | 5.88 |
Gm15774 |
predicted gene 15774 |
10026 |
0.13 |
chr1_155040164_155040623 | 5.87 |
Gm29441 |
predicted gene 29441 |
8654 |
0.18 |
chr4_116720426_116721428 | 5.86 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr15_103258381_103258750 | 5.86 |
Nfe2 |
nuclear factor, erythroid derived 2 |
162 |
0.91 |
chr1_134163557_134163719 | 5.84 |
Chil1 |
chitinase-like 1 |
18538 |
0.12 |
chr11_84818681_84819716 | 5.83 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
317 |
0.83 |
chr19_46396648_46397747 | 5.82 |
Sufu |
SUFU negative regulator of hedgehog signaling |
171 |
0.89 |
chr9_54483232_54483388 | 5.81 |
Dmxl2 |
Dmx-like 2 |
9127 |
0.21 |
chrX_169036429_169036766 | 5.78 |
Arhgap6 |
Rho GTPase activating protein 6 |
14 |
0.99 |
chr10_61123250_61123407 | 5.77 |
Gm44308 |
predicted gene, 44308 |
1907 |
0.27 |
chr14_27428926_27429160 | 5.76 |
Tasor |
transcription activation suppressor |
209 |
0.94 |
chr7_5060805_5061447 | 5.76 |
Gm45133 |
predicted gene 45133 |
923 |
0.22 |
chr11_78071743_78072223 | 5.76 |
Mir144 |
microRNA 144 |
1022 |
0.22 |
chr8_123988622_123988985 | 5.75 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
5681 |
0.11 |
chr4_133057809_133058081 | 5.73 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
8304 |
0.2 |
chr11_121433525_121433761 | 5.73 |
Fn3k |
fructosamine 3 kinase |
1270 |
0.33 |
chr11_69609481_69609762 | 5.72 |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
3679 |
0.07 |
chr2_32083621_32084073 | 5.70 |
Fam78a |
family with sequence similarity 78, member A |
64 |
0.95 |
chr7_120981517_120981887 | 5.70 |
Cdr2 |
cerebellar degeneration-related 2 |
88 |
0.91 |
chr4_148040533_148041286 | 5.70 |
Mthfr |
methylenetetrahydrofolate reductase |
99 |
0.92 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.2 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
3.9 | 11.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
3.3 | 10.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
3.3 | 10.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
3.1 | 9.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
2.6 | 13.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.4 | 7.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.4 | 9.7 | GO:0008228 | opsonization(GO:0008228) |
2.4 | 9.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.4 | 7.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
2.4 | 7.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.3 | 9.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.2 | 9.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
2.2 | 13.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
2.2 | 8.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
2.2 | 6.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.1 | 6.3 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.1 | 8.4 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
2.1 | 6.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
2.1 | 6.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.1 | 6.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.0 | 6.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
2.0 | 10.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
2.0 | 10.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
2.0 | 6.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.9 | 5.8 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.9 | 11.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.9 | 5.7 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.9 | 5.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.9 | 5.7 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.9 | 5.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
1.9 | 5.7 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.9 | 5.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.9 | 7.5 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.9 | 5.6 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
1.8 | 5.3 | GO:0040031 | snRNA modification(GO:0040031) |
1.8 | 3.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.8 | 10.6 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
1.7 | 5.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.7 | 5.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.7 | 5.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.7 | 5.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.6 | 4.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.6 | 6.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.6 | 4.7 | GO:0035973 | aggrephagy(GO:0035973) |
1.6 | 4.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.5 | 12.4 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.5 | 4.6 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.5 | 4.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.5 | 6.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.5 | 7.4 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
1.5 | 5.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.4 | 4.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.4 | 7.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.4 | 4.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.4 | 7.2 | GO:0006116 | NADH oxidation(GO:0006116) |
1.4 | 5.7 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.4 | 5.6 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
1.4 | 4.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.4 | 4.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.3 | 5.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.3 | 4.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.3 | 7.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.3 | 4.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.3 | 3.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.3 | 5.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.3 | 3.9 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
1.3 | 5.2 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.3 | 3.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.3 | 1.3 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.3 | 12.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
1.3 | 11.5 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.3 | 7.6 | GO:0048539 | bone marrow development(GO:0048539) |
1.3 | 3.8 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
1.2 | 3.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.2 | 8.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.2 | 4.9 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.2 | 4.8 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.2 | 3.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.2 | 12.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
1.2 | 1.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.2 | 5.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.2 | 4.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.2 | 3.5 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.2 | 8.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
1.1 | 2.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.1 | 4.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
1.1 | 5.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.1 | 2.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.1 | 3.3 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
1.1 | 1.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.1 | 3.3 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.1 | 4.3 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.1 | 2.2 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 3.2 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.1 | 7.4 | GO:0006265 | DNA topological change(GO:0006265) |
1.1 | 2.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.0 | 2.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.0 | 10.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.0 | 3.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.0 | 2.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
1.0 | 5.1 | GO:0009642 | response to light intensity(GO:0009642) |
1.0 | 4.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
1.0 | 3.1 | GO:0045472 | response to ether(GO:0045472) |
1.0 | 2.0 | GO:0070295 | renal water absorption(GO:0070295) |
1.0 | 3.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.0 | 3.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.0 | 3.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.0 | 5.0 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
1.0 | 4.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.0 | 2.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
1.0 | 10.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.0 | 3.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.0 | 3.9 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.0 | 4.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.0 | 2.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.0 | 3.9 | GO:0070836 | caveola assembly(GO:0070836) |
1.0 | 11.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.0 | 1.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.0 | 3.9 | GO:0060374 | mast cell differentiation(GO:0060374) |
1.0 | 2.9 | GO:0008050 | female courtship behavior(GO:0008050) |
1.0 | 4.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.0 | 2.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.0 | 2.9 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.0 | 7.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.9 | 3.8 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.9 | 0.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.9 | 9.5 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.9 | 3.8 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.9 | 3.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.9 | 2.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.9 | 12.2 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.9 | 2.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.9 | 10.2 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.9 | 2.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.9 | 3.7 | GO:0072553 | terminal button organization(GO:0072553) |
0.9 | 4.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.9 | 1.8 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.9 | 1.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.9 | 2.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.9 | 2.7 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.9 | 8.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.9 | 9.0 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.9 | 6.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.9 | 5.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.9 | 5.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.9 | 1.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.9 | 4.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.9 | 1.7 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.9 | 1.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.9 | 2.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.9 | 0.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.9 | 4.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.9 | 1.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.8 | 5.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.8 | 3.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.8 | 2.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.8 | 5.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.8 | 2.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.8 | 2.5 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.8 | 5.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.8 | 2.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.8 | 3.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.8 | 4.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.8 | 4.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.8 | 4.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.8 | 2.4 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.8 | 3.2 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.8 | 3.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 2.4 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.8 | 2.4 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.8 | 8.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.8 | 0.8 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.8 | 3.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.8 | 2.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.8 | 5.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 3.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.8 | 3.1 | GO:0015074 | DNA integration(GO:0015074) |
0.8 | 2.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.8 | 3.8 | GO:0015886 | heme transport(GO:0015886) |
0.8 | 3.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.8 | 2.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.8 | 5.3 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.8 | 5.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.8 | 1.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.8 | 6.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.8 | 7.5 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.7 | 0.7 | GO:2000756 | negative regulation of protein acetylation(GO:1901984) regulation of peptidyl-lysine acetylation(GO:2000756) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.7 | 3.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.7 | 3.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.7 | 5.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.7 | 0.7 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.7 | 2.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.7 | 2.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.7 | 4.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.7 | 5.2 | GO:0043486 | histone exchange(GO:0043486) |
0.7 | 3.0 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.7 | 5.9 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.7 | 1.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.7 | 3.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.7 | 5.8 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.7 | 4.3 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.7 | 0.7 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.7 | 5.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.7 | 2.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.7 | 2.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.7 | 1.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.7 | 1.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.7 | 2.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.7 | 12.8 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.7 | 2.9 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.7 | 4.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.7 | 3.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.7 | 3.5 | GO:0015871 | choline transport(GO:0015871) |
0.7 | 4.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 1.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.7 | 1.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.7 | 3.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.7 | 4.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.7 | 2.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.7 | 2.8 | GO:0009838 | abscission(GO:0009838) |
0.7 | 3.5 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.7 | 2.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 11.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.7 | 3.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.7 | 2.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.7 | 2.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.7 | 2.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 2.0 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 1.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.7 | 1.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.7 | 7.4 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.7 | 4.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.7 | 10.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.7 | 4.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.7 | 4.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.7 | 2.0 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.7 | 2.6 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.7 | 7.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 1.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.7 | 1.3 | GO:0033483 | gas homeostasis(GO:0033483) |
0.7 | 0.7 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.6 | 3.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.6 | 2.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 | 3.9 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.6 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.6 | 1.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 3.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.6 | 5.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.6 | 1.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.6 | 5.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.6 | 5.7 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.6 | 7.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.6 | 1.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.6 | 3.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 1.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.6 | 2.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.6 | 4.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.6 | 4.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.6 | 1.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.6 | 4.4 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.6 | 2.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.6 | 4.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.6 | 2.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.6 | 6.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.6 | 1.8 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.6 | 3.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.6 | 5.5 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.6 | 3.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.6 | 1.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.6 | 8.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.6 | 11.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.6 | 1.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 2.4 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.6 | 4.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.6 | 6.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 4.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.6 | 1.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.6 | 0.6 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.6 | 2.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 7.7 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.6 | 4.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 1.8 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.6 | 0.6 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.6 | 4.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.6 | 6.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 1.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 2.3 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.6 | 1.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.6 | 4.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.6 | 2.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.6 | 0.6 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.6 | 3.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.6 | 3.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 1.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.6 | 2.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.6 | 2.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.6 | 0.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 7.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 1.7 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.6 | 1.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 1.7 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.6 | 1.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.6 | 1.7 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.6 | 1.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.6 | 0.6 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.6 | 2.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.6 | 1.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 5.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.6 | 1.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.6 | 3.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 3.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.5 | 1.1 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.5 | 1.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.5 | 2.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 1.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.5 | 2.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.5 | 1.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.5 | 7.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.5 | 1.6 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.5 | 4.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 1.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.5 | 2.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 1.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.5 | 1.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 1.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.5 | 3.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.5 | 1.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.5 | 2.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.5 | 2.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.5 | 2.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 2.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.5 | 2.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.5 | 2.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.5 | 1.0 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.5 | 1.0 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 3.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 2.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.5 | 2.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 4.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.5 | 4.1 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.5 | 1.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.5 | 1.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.5 | 1.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 1.5 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.5 | 1.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.5 | 1.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.5 | 2.5 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.5 | 2.0 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) |
0.5 | 2.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 2.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.5 | 1.0 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.5 | 2.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.5 | 2.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 0.5 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.5 | 2.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 3.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 2.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.5 | 1.5 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.5 | 1.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 1.5 | GO:0051610 | serotonin uptake(GO:0051610) |
0.5 | 13.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 5.9 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.5 | 0.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 1.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.5 | 1.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 0.5 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.5 | 2.9 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.5 | 1.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.5 | 2.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.5 | 4.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 1.9 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.5 | 3.4 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.5 | 1.9 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.5 | 8.6 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.5 | 2.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.5 | 2.9 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.5 | 1.9 | GO:0006415 | translational termination(GO:0006415) |
0.5 | 1.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 6.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 1.4 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.5 | 1.4 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.5 | 1.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 0.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.5 | 0.9 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.5 | 2.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.5 | 9.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.5 | 1.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.5 | 3.7 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.5 | 1.4 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.5 | 3.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.5 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 5.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 1.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 1.8 | GO:0019230 | proprioception(GO:0019230) |
0.4 | 2.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.4 | 3.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.4 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 1.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 1.3 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 4.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.4 | 0.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 1.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 2.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.4 | 0.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.4 | 1.7 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 1.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 2.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 9.3 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.4 | 1.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 0.4 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.4 | 2.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.4 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 0.4 | GO:0015819 | lysine transport(GO:0015819) |
0.4 | 0.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 0.4 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.4 | 1.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 0.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 1.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.4 | 5.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 2.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 0.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 0.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 0.8 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.4 | 2.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 1.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 1.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 0.4 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 6.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.4 | 2.0 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.4 | 1.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 2.4 | GO:0015677 | copper ion import(GO:0015677) |
0.4 | 4.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.4 | 1.6 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.4 | 1.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.4 | 1.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.4 | 0.4 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 1.2 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 1.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 4.8 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.4 | 2.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 2.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 2.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.4 | 0.8 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 0.8 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.4 | 1.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.4 | 1.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.4 | 1.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.4 | 0.4 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 1.6 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.4 | 0.4 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.4 | 4.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 14.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.4 | 1.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.4 | 15.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 0.8 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 0.8 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.4 | 0.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 5.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.4 | 1.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 1.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 3.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 3.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.4 | 0.4 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.4 | 1.9 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 1.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.4 | 1.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 1.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 0.7 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.4 | 0.7 | GO:0035425 | autocrine signaling(GO:0035425) |
0.4 | 0.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 1.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.4 | 2.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 0.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 1.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 0.7 | GO:0002894 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.4 | 1.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.4 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 0.7 | GO:0007127 | meiosis I(GO:0007127) |
0.4 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 0.4 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.4 | 1.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.4 | 6.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.4 | 1.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 5.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.4 | 1.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 4.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.4 | 0.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.4 | 1.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.4 | 0.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.4 | 1.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 1.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.4 | 0.7 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.4 | 1.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.3 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 6.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.3 | 3.1 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.3 | 9.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.3 | 1.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 0.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 0.3 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.3 | 14.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.3 | 1.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 1.4 | GO:0000237 | leptotene(GO:0000237) |
0.3 | 1.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 1.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.3 | 1.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 0.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 5.4 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 0.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.3 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 2.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 1.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 4.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 1.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 0.3 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 1.0 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 2.9 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.3 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.3 | 1.0 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 2.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 3.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.3 | 0.6 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 1.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 1.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 1.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.3 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 2.2 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.3 | 2.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 1.9 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.3 | 3.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 1.3 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 0.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 0.6 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 0.6 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.3 | 0.9 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 0.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.3 | 3.8 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.3 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 0.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 1.6 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.3 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 0.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 6.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 3.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 5.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 0.6 | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response(GO:1900101) |
0.3 | 1.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 1.9 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.3 | 0.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 0.3 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.3 | 1.2 | GO:0033572 | transferrin transport(GO:0033572) |
0.3 | 0.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 2.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 0.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.3 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 1.8 | GO:0050779 | RNA destabilization(GO:0050779) |
0.3 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 0.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 1.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 0.9 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 0.6 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.3 | 1.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 2.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 1.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 0.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 7.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.3 | 5.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 8.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 0.9 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 1.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.3 | 0.6 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.3 | 1.2 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 1.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 1.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 0.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 1.7 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 2.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.3 | 4.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 2.9 | GO:0006298 | mismatch repair(GO:0006298) |
0.3 | 4.6 | GO:0007143 | female meiotic division(GO:0007143) |
0.3 | 0.6 | GO:0044532 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.3 | 0.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 1.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 1.7 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.3 | 0.3 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.3 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.6 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.3 | 0.6 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 1.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.7 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.3 | 2.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 1.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 1.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.3 | 0.8 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.3 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.3 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 2.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.3 | 1.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 1.4 | GO:0044774 | mitotic DNA integrity checkpoint(GO:0044774) |
0.3 | 1.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 1.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 0.3 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 3.8 | GO:0036230 | granulocyte activation(GO:0036230) |
0.3 | 0.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 0.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 1.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 2.4 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 3.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 1.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 6.2 | GO:0016575 | histone deacetylation(GO:0016575) |
0.3 | 0.8 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.3 | 3.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 1.9 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 0.8 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.3 | 0.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 2.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 2.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 0.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 0.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 1.8 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.3 | 1.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.3 | 0.3 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.3 | 1.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 1.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 1.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.3 | 0.8 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 0.5 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.3 | 0.8 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.3 | 1.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 1.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 1.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 2.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 0.5 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.3 | 0.3 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.3 | 2.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 2.0 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.3 | 1.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.3 | 4.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 1.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 1.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 2.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 1.0 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 0.2 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 0.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.2 | 0.5 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.2 | 0.2 | GO:0046112 | purine nucleobase biosynthetic process(GO:0009113) nucleobase biosynthetic process(GO:0046112) |
0.2 | 1.5 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.2 | 0.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 4.1 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.2 | 1.2 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 8.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 2.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 9.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.2 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 1.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 1.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 2.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 2.1 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.9 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.2 | 0.7 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 0.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 2.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.9 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 0.7 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 3.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.7 | GO:0046931 | pore complex assembly(GO:0046931) |
0.2 | 6.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 0.7 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 2.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 2.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 1.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 1.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 1.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.4 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.2 | 2.9 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.2 | 1.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.9 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.7 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 1.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 3.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 1.7 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.2 | 0.7 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 2.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 1.5 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.2 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 1.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 1.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 1.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.6 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.2 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.6 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 3.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.2 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.4 | GO:1900364 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 0.4 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.2 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.2 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.2 | 3.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.6 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.2 | 0.8 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 1.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 1.0 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.2 | 1.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 3.0 | GO:0016073 | snRNA metabolic process(GO:0016073) snRNA processing(GO:0016180) |
0.2 | 1.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.2 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.4 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.2 | 1.0 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.2 | 2.8 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 0.2 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 1.8 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 2.6 | GO:0070265 | necrotic cell death(GO:0070265) |
0.2 | 0.2 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.8 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.2 | 0.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.2 | 1.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 9.8 | GO:0050821 | protein stabilization(GO:0050821) |
0.2 | 0.8 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 2.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 4.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 2.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.2 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.2 | 0.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.2 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.2 | 0.8 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 1.7 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 1.3 | GO:0002385 | mucosal immune response(GO:0002385) |
0.2 | 3.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 2.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.2 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.9 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.9 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 1.3 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.2 | 0.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.2 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.2 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.2 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.2 | 0.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.2 | 1.3 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.5 | GO:0006342 | chromatin silencing(GO:0006342) |
0.2 | 0.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.5 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 1.3 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 11.0 | GO:0006457 | protein folding(GO:0006457) |
0.2 | 0.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 1.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 1.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.7 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 1.2 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.2 | 0.5 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.2 | 1.6 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.4 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.2 | 0.5 | GO:0006862 | nucleotide transport(GO:0006862) |
0.2 | 0.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.4 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 0.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 1.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.5 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 3.2 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 4.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 0.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 0.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 3.9 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.8 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.2 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) meiotic cytokinesis(GO:0033206) |
0.2 | 0.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.3 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 0.6 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 0.3 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.2 | 0.6 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 4.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.6 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.2 | 0.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 1.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 1.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 1.1 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.8 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 0.3 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.2 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.6 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 0.8 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.5 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.9 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.8 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 1.2 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 2.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 4.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 1.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 3.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.4 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.3 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.1 | 0.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 1.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.8 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.3 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 2.0 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 2.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 4.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.1 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.1 | 0.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.8 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 2.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 0.4 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.4 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.1 | 2.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.6 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 1.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 1.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 1.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 1.1 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 1.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 4.2 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.7 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.1 | 1.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 4.6 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.5 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.4 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.1 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.3 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 2.3 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.1 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.1 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 1.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 1.9 | GO:0006754 | ATP biosynthetic process(GO:0006754) purine nucleoside triphosphate biosynthetic process(GO:0009145) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.6 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.1 | 0.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.4 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.1 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 1.2 | GO:0048753 | pigment granule organization(GO:0048753) |
0.1 | 0.3 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 1.8 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.1 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 1.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.1 | GO:0009310 | amine catabolic process(GO:0009310) |
0.1 | 1.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.2 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 2.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.4 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.5 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 1.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 1.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 1.4 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
0.1 | 0.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 1.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.3 | GO:0098751 | bone cell development(GO:0098751) |
0.1 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.1 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0009164 | nucleoside catabolic process(GO:0009164) |
0.1 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.1 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.1 | 0.2 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.1 | 0.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.2 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.3 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 1.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 1.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.4 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.6 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.1 | GO:0071635 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 1.0 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.2 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 3.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 2.2 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.1 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.5 | GO:0032784 | DNA-templated transcription, elongation(GO:0006354) regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.8 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 1.3 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.2 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 0.1 | GO:1903551 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 1.6 | GO:0006639 | acylglycerol metabolic process(GO:0006639) |
0.1 | 0.4 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.1 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.1 | 1.0 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.2 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.2 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 0.1 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 2.0 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.4 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.4 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.7 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.1 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.2 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.9 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 0.4 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.3 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.1 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 1.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.5 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.2 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.2 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.1 | GO:0031649 | heat generation(GO:0031649) positive regulation of heat generation(GO:0031652) |
0.1 | 0.6 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.1 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.2 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.1 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.1 | 0.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.0 | 0.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.0 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.0 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.3 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.0 | 1.0 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:0097286 | iron ion import(GO:0097286) |
0.0 | 0.2 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.6 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.0 | 0.0 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.0 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.0 | 1.3 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 3.6 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.0 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.0 | 0.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.0 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.3 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.0 | 0.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.0 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.0 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.0 | 1.7 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.4 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.0 | 0.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.0 | 0.0 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.0 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.6 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.0 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 1.2 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 1.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.0 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.0 | 0.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.1 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.0 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.0 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.0 | 0.1 | GO:0071827 | plasma lipoprotein particle organization(GO:0071827) |
0.0 | 0.0 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.0 | 0.1 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
0.0 | 0.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.1 | GO:0019915 | lipid storage(GO:0019915) |
0.0 | 0.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.0 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.0 | 0.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.0 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.0 | 1.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.0 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.0 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.0 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
0.0 | 0.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.0 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 14.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
2.1 | 8.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.0 | 5.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.0 | 7.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.9 | 5.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.8 | 5.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.7 | 5.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.7 | 10.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.6 | 16.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.5 | 5.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.4 | 5.6 | GO:0005642 | annulate lamellae(GO:0005642) |
1.4 | 5.5 | GO:0072487 | MSL complex(GO:0072487) |
1.4 | 5.5 | GO:0098536 | deuterosome(GO:0098536) |
1.3 | 3.9 | GO:0097443 | sorting endosome(GO:0097443) |
1.3 | 16.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.3 | 3.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.2 | 5.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.2 | 6.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.2 | 7.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.2 | 7.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.2 | 2.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.1 | 8.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.1 | 3.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.1 | 3.4 | GO:0031523 | Myb complex(GO:0031523) |
1.1 | 5.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.1 | 10.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.1 | 3.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.0 | 3.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.0 | 7.1 | GO:0042382 | paraspeckles(GO:0042382) |
1.0 | 3.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.0 | 3.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.9 | 3.7 | GO:0042825 | TAP complex(GO:0042825) |
0.9 | 0.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) periciliary membrane compartment(GO:1990075) |
0.9 | 52.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.9 | 11.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.9 | 14.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.9 | 6.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.9 | 2.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.9 | 7.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.9 | 7.8 | GO:0051286 | cell tip(GO:0051286) |
0.9 | 2.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.9 | 3.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.8 | 12.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.8 | 0.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.8 | 8.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.8 | 3.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.8 | 4.1 | GO:0090543 | Flemming body(GO:0090543) |
0.8 | 4.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.8 | 16.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.8 | 2.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.8 | 7.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.8 | 6.2 | GO:0034464 | BBSome(GO:0034464) |
0.8 | 6.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.8 | 3.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.8 | 2.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.8 | 3.8 | GO:0005818 | aster(GO:0005818) |
0.8 | 4.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.8 | 3.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 3.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.7 | 6.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.7 | 6.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.7 | 2.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 9.6 | GO:0036038 | MKS complex(GO:0036038) |
0.7 | 9.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.7 | 3.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.7 | 7.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.7 | 2.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.7 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
0.7 | 4.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 23.3 | GO:0016592 | mediator complex(GO:0016592) |
0.7 | 10.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.7 | 4.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.7 | 2.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.7 | 2.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 5.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 2.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.7 | 3.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.7 | 8.5 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.7 | 2.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 15.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.6 | 1.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.6 | 5.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 2.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.6 | 1.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.6 | 3.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.6 | 2.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.6 | 1.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 2.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.6 | 2.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 20.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 10.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.6 | 2.4 | GO:0000938 | GARP complex(GO:0000938) |
0.6 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.6 | 1.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.6 | 1.8 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.6 | 7.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.6 | 3.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.6 | 4.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.6 | 1.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.6 | 1.8 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.6 | 5.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.6 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.6 | 2.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.6 | 4.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.6 | 1.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.6 | 2.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.6 | 8.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.6 | 2.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.6 | 1.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 2.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.5 | 24.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.5 | 4.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.5 | 1.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.5 | 1.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.5 | 4.8 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.5 | 1.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.5 | 13.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.5 | 13.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.5 | 22.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 1.5 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 6.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.5 | 32.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 19.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.5 | 6.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.5 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.5 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 1.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 0.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 0.9 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 0.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.5 | 5.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.5 | 0.9 | GO:0016528 | sarcoplasm(GO:0016528) |
0.5 | 2.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.5 | 1.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 2.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.5 | 3.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 3.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.4 | 2.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 5.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 1.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 4.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 6.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 3.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 3.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 12.4 | GO:0005776 | autophagosome(GO:0005776) |
0.4 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.4 | 1.7 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 1.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 3.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 4.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.4 | 3.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 1.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 8.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 2.4 | GO:0000801 | central element(GO:0000801) |
0.4 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 4.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 4.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 2.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.4 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 1.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 2.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.4 | 2.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 2.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.4 | 2.3 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 1.2 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 1.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 0.8 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 1.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 3.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.4 | 4.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.4 | 15.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 3.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 0.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 3.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.4 | 2.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 1.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 4.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.4 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 2.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 4.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 1.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 25.6 | GO:0000776 | kinetochore(GO:0000776) |
0.4 | 1.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 8.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 21.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.4 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 2.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 3.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 2.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 1.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 0.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 4.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 1.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 5.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.3 | 33.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 4.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 0.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 1.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 1.3 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 1.0 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 2.2 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 2.5 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.3 | 0.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 2.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 11.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 1.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 0.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 1.8 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.3 | 10.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 5.3 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 2.0 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 0.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 2.3 | GO:0031430 | M band(GO:0031430) |
0.3 | 4.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 9.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 13.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 5.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.3 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 3.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 6.3 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 2.7 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 1.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 0.3 | GO:0097346 | INO80-type complex(GO:0097346) |
0.3 | 3.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 2.9 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 11.9 | GO:0016605 | PML body(GO:0016605) |
0.3 | 0.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 3.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 2.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 2.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 0.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 1.2 | GO:0044452 | nucleolar part(GO:0044452) |
0.2 | 2.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 2.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 3.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 0.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 8.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 3.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.5 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 0.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 11.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 5.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 4.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 10.4 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 8.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 0.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 1.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 21.6 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 4.2 | GO:0030496 | midbody(GO:0030496) |
0.2 | 1.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 12.0 | GO:0005819 | spindle(GO:0005819) |
0.2 | 0.9 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 0.9 | GO:0030016 | myofibril(GO:0030016) |
0.2 | 18.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 3.0 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 11.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 19.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 1.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 9.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 14.7 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.2 | 10.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 5.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.6 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 1.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 0.8 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 1.1 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 1.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 2.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 1.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 2.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 11.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 47.9 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 0.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.7 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.2 | 4.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 1.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 9.5 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 1.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 3.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 10.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 0.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.2 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 1.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 2.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 5.0 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 25.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 3.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 131.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.1 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 4.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 119.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.4 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 1.2 | GO:0033646 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.1 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 3.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 2.1 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.5 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 3.6 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 2.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.1 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 2.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 5.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 4.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.2 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 15.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 11.8 | GO:1902494 | catalytic complex(GO:1902494) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 2.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 16.1 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.6 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.1 | 3.8 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 1.9 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.4 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 6.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 2.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.6 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 39.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.0 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.4 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
3.5 | 10.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.5 | 14.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
3.0 | 11.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.7 | 10.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.6 | 7.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.5 | 7.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
2.4 | 7.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.1 | 6.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.0 | 8.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.0 | 8.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.9 | 5.8 | GO:0004359 | glutaminase activity(GO:0004359) |
1.9 | 1.9 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.8 | 7.4 | GO:0043515 | kinetochore binding(GO:0043515) |
1.7 | 5.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.7 | 1.7 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
1.7 | 5.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.7 | 6.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.6 | 8.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.5 | 6.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.5 | 6.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.5 | 6.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.4 | 1.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.4 | 4.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.3 | 16.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.3 | 4.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.3 | 3.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.3 | 3.8 | GO:0050692 | DBD domain binding(GO:0050692) |
1.2 | 3.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.2 | 9.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.2 | 3.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.2 | 9.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.2 | 6.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
1.2 | 1.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.2 | 3.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.2 | 9.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.2 | 2.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
1.2 | 3.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.1 | 3.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.1 | 3.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.1 | 3.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.1 | 1.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
1.1 | 4.3 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.1 | 8.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.1 | 7.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
1.1 | 5.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 12.8 | GO:0048156 | tau protein binding(GO:0048156) |
1.1 | 4.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.0 | 3.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.0 | 4.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.0 | 3.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.0 | 1.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
1.0 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
1.0 | 4.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.0 | 4.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.0 | 6.7 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.0 | 3.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.9 | 8.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.9 | 8.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.9 | 5.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.9 | 5.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.9 | 0.9 | GO:0070538 | oleic acid binding(GO:0070538) |
0.9 | 6.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 0.9 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.9 | 24.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.9 | 8.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.9 | 7.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.9 | 17.0 | GO:0001848 | complement binding(GO:0001848) |
0.9 | 0.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.9 | 4.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.9 | 3.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.9 | 2.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.9 | 3.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.9 | 2.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 2.5 | GO:0043888 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.8 | 4.2 | GO:0070061 | fructose binding(GO:0070061) |
0.8 | 5.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.8 | 2.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.8 | 3.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.8 | 1.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.8 | 2.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 4.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.8 | 0.8 | GO:0035877 | death effector domain binding(GO:0035877) |
0.8 | 4.0 | GO:0070728 | leucine binding(GO:0070728) |
0.8 | 11.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.8 | 10.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.8 | 5.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.8 | 3.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.8 | 3.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.8 | 2.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.8 | 3.9 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.8 | 1.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.8 | 22.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.8 | 6.1 | GO:0046977 | TAP binding(GO:0046977) |
0.8 | 6.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 3.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.7 | 0.7 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.7 | 3.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.7 | 4.4 | GO:0043559 | insulin binding(GO:0043559) |
0.7 | 6.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.7 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.7 | 1.4 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.7 | 12.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.7 | 3.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.7 | 5.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.7 | 6.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.7 | 3.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.7 | 4.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.7 | 3.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 4.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.7 | 6.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.7 | 3.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 2.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.7 | 2.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 4.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.7 | 2.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.7 | 2.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.7 | 2.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 2.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.7 | 3.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.7 | 12.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 5.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.7 | 3.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.7 | 2.0 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 3.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.6 | 4.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 1.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.6 | 1.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.6 | 1.9 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.6 | 12.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.6 | 3.8 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.6 | 3.2 | GO:0019113 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.6 | 13.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.6 | 3.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.6 | 2.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.6 | 2.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 8.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.6 | 2.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 2.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.6 | 12.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.6 | 1.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 3.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 1.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 4.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 3.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.6 | 15.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.6 | 3.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.6 | 1.8 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.6 | 2.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 2.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 1.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.6 | 2.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.6 | 1.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.6 | 4.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.6 | 3.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 4.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 3.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 1.7 | GO:0051731 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.6 | 1.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 3.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 4.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.5 | 1.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.5 | 13.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 1.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.5 | 5.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 4.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 1.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.5 | 5.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.5 | 2.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.5 | 1.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 7.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 3.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 3.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.5 | 6.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 1.6 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.5 | 1.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 2.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.5 | 4.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.5 | 2.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 0.5 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.5 | 2.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 3.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.5 | 2.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.5 | 3.0 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.5 | 2.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 12.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.5 | 4.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 1.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.5 | 10.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.5 | 16.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.5 | 1.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.5 | 10.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.5 | 3.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.5 | 9.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.5 | 1.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.5 | 2.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 4.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 1.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.5 | 0.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.5 | 2.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 1.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 1.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 1.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 6.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 10.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.5 | 1.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 5.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 3.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 0.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 4.0 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.4 | 4.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 2.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 1.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 6.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 2.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 1.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 2.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 5.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.4 | 2.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 1.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 12.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.4 | 1.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 2.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 1.3 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 6.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 6.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.4 | 1.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.4 | 1.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 2.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.4 | 1.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 0.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 4.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 1.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.4 | 2.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 0.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 8.0 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 2.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 3.6 | GO:0034863 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 8.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 2.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 2.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 1.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 3.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.4 | 1.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 3.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 1.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 5.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 1.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 1.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 0.4 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.4 | 2.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 1.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.4 | 3.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 3.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 1.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 22.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.4 | 3.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 4.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 4.7 | GO:0019003 | GDP binding(GO:0019003) |
0.4 | 1.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 17.9 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.4 | 1.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 2.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 13.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 1.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 2.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 3.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 3.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 2.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 2.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 2.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.3 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 1.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 5.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 1.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 0.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 2.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 3.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 1.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 1.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 7.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 9.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 2.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 1.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 11.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.3 | 2.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 7.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 1.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 10.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 1.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 2.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 9.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 46.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 1.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 1.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 5.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.3 | 2.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 2.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 0.9 | GO:0019213 | deacetylase activity(GO:0019213) |
0.3 | 1.6 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.3 | 2.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 2.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 1.8 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 0.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 4.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 0.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 0.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 0.9 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 1.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 6.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.3 | 0.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 0.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.3 | 3.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 4.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 2.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 1.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 0.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 15.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 0.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.3 | 32.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.3 | 9.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 19.2 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 1.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 0.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 0.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 2.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 4.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 15.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.3 | 0.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 0.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 0.5 | GO:0070990 | snRNP binding(GO:0070990) |
0.3 | 0.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 0.5 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.3 | 0.5 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.3 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 2.7 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 1.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 1.3 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 9.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 1.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 0.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 0.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 1.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 4.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.3 | 2.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 16.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 1.5 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 1.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 5.3 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 3.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 3.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.5 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.2 | 23.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 4.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 3.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 2.9 | GO:0000907 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 1.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 3.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 2.4 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 0.9 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 2.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 1.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 0.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 3.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 1.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 4.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 1.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 1.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 2.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 2.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.8 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 0.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 2.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 2.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 3.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 1.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 0.6 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 4.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 1.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 1.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 2.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 1.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 2.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 6.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 1.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 1.5 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 17.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 3.7 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 11.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 4.4 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 1.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 4.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 1.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.2 | 2.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.0 | GO:0017069 | snRNA binding(GO:0017069) |
0.2 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.5 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 2.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 0.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 6.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 1.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 1.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 1.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 13.3 | GO:0004519 | endonuclease activity(GO:0004519) |
0.2 | 13.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 17.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 7.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 4.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 4.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 29.0 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 4.0 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 2.3 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 2.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 5.8 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 15.8 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.4 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 1.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 2.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 5.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 3.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.8 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 2.8 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 80.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 1.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 1.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.5 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 3.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.2 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 1.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 2.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.6 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 2.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 2.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 3.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 2.5 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.5 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.7 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 1.5 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 1.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 2.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.4 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 2.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.0 | GO:0010296 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 9.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 1.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.5 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.5 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 1.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 1.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 2.0 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.2 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.2 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.2 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.0 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 2.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0018586 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 1.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 3.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.1 | GO:0072542 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.0 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.8 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 1.2 | GO:0000988 | transcription factor activity, protein binding(GO:0000988) |
0.0 | 0.0 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 1.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 15.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.2 | 13.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.0 | 2.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.0 | 36.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.9 | 6.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.9 | 14.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.8 | 11.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 32.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.8 | 2.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.8 | 5.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 18.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.7 | 1.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.7 | 19.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.6 | 12.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.6 | 8.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.6 | 18.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.6 | 7.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.6 | 7.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 19.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 20.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 2.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 3.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 10.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 18.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 6.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 4.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 1.5 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 4.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 3.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 7.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 6.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 22.2 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 0.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 7.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 3.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 15.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 2.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 7.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 15.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 18.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 2.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 20.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 11.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 9.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 4.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 5.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 4.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 9.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 9.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 4.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 1.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 3.4 | PID ATM PATHWAY | ATM pathway |
0.3 | 9.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 1.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 3.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 7.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 6.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 5.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 1.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 8.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 0.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 11.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 4.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 3.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 4.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 2.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 2.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 3.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 2.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 5.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 6.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 1.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 2.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 2.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 1.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 2.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 2.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 2.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 4.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 3.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 1.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 1.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 2.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 3.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 4.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 23.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.7 | 18.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.6 | 15.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.2 | 19.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.2 | 20.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
1.2 | 2.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.1 | 11.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.1 | 15.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.0 | 24.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.0 | 16.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.0 | 2.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.0 | 11.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
1.0 | 2.9 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
1.0 | 1.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.0 | 11.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.9 | 12.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.9 | 22.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.8 | 3.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.8 | 2.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.8 | 9.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.8 | 14.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.8 | 7.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.8 | 4.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.8 | 9.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 8.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 5.0 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.7 | 9.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.7 | 2.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.6 | 44.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.6 | 4.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.6 | 11.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.6 | 10.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.6 | 8.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.6 | 9.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 5.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 7.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.6 | 13.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.5 | 6.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 7.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.5 | 7.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.5 | 5.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 9.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.5 | 5.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 7.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 2.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 6.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 6.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 11.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 6.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.5 | 4.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.5 | 5.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 12.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.5 | 6.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 12.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 4.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 16.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 0.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.5 | 31.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.4 | 3.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 4.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.4 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 4.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 1.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 10.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 2.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 1.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 2.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 0.9 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 1.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.4 | 0.4 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.4 | 1.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 4.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 5.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 5.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 6.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 1.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 4.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 4.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 5.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 9.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 6.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 2.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 13.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 5.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 28.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 5.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 5.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 5.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 5.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 6.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 7.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 3.7 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.3 | 5.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 4.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 3.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 7.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.3 | 3.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 14.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 4.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 4.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 6.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 2.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 2.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 5.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 2.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 0.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 4.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 3.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 6.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 8.8 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.3 | 12.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 3.6 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 7.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 31.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 1.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.3 | 1.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 0.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 4.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 3.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 2.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 2.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 3.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 0.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 6.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 2.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 5.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.4 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.2 | 9.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 2.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 4.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 0.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 1.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.8 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.2 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 3.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 2.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 4.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 2.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 2.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 3.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.7 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 2.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 3.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.7 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 5.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 4.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 2.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.4 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 2.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 1.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 1.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.2 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.0 | 0.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 1.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |